Biolife Solutions (BLFS) Capital Expenditures Growth (3y) (2013 - 2026)
Biolife Solutions (BLFS) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -18.96% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -11.61% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 5.31% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -31.75% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 5.49% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -21.70% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -6.01% |
| 10 | Biolife Solutions | 1.27 Bn | 1.19 Bn | 17.50 Mn | -62.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62.99% |
| Dec 31, 2025 | 54.02% |
| Sep 30, 2025 | -37.51% |
| Jun 30, 2025 | -5.03% |
| Mar 31, 2025 | -50.65% |
| Dec 31, 2024 | -54.48% |
| Sep 30, 2024 | 36.21% |
| Jun 30, 2024 | -53.17% |
| Mar 31, 2024 | -75.27% |
| Dec 31, 2023 | 66.93% |
| Sep 30, 2023 | 132.52% |
| Jun 30, 2023 | 35.46% |
| Mar 31, 2023 | 718.91% |
| Dec 31, 2022 | -260.01% |
| Sep 30, 2022 | 181.82% |
| Jun 30, 2022 | 109.92% |
| Mar 31, 2022 | 110.55% |
| Dec 31, 2021 | 1,073.49% |
| Sep 30, 2021 | -423.48% |
| Jun 30, 2021 | 406.52% |